INIS
accumulation
100%
lipids
100%
homeostasis
100%
humans
50%
receptors
50%
mice
50%
production
50%
enzymes
50%
diseases
25%
tissues
25%
regulations
25%
density
25%
vessels
25%
interventions
25%
rna
25%
mass spectrometry
25%
liquid column chromatography
25%
proteins
25%
synthesis
25%
precursor
25%
carotid arteries
25%
lipoproteins
25%
calcium
25%
Keyphrases
Homeostasis
100%
Atherosclerotic Lesions
100%
Lesion Progression
100%
Lysophosphatidic Acid
100%
Plaque
45%
Phospholipase A2 (PLA2)
36%
Acid Production
18%
Immunohistochemistry
9%
Gene-deficient Mice
9%
Disease Stage
9%
Atherosclerotic Plaque
9%
Platelets
9%
Lipids
9%
Disease Progression
9%
Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS)
9%
Carotid Artery
9%
Thrombogenicity
9%
Atherogenesis
9%
Intraplaque
9%
Plaque Progression
9%
Atheroma
9%
Low-density Lipoprotein Receptor
9%
Thrombogenic
9%
Advanced Lesions
9%
Lysophosphatidylcholine
9%
Calcium-independent
9%
Proinflammatory Lipids
9%
Acid Content
9%
Lipid Constituents
9%
Lipid Profiling
9%
Enzymatic Regulation
9%
Lysophosphatidic Acid Receptor 2
9%
Lysophosphatidic Acid Receptor 1
9%
Hydrolytic Enzymes
9%
Lysophosphatidic Acid Acyltransferase (LPAAT)
9%
Vessel Segment
9%
Medicine and Dentistry
Homeostasis
100%
Lysophosphatidic Acid
100%
Acid
16%
Phospholipase A
16%
Immunohistochemistry
8%
Precursor
8%
Isotopes of Calcium
8%
Carotid Artery
8%
Platelet
8%
LDL Receptor
8%
Liquid Chromatography-Mass Spectrometry
8%
Disease Exacerbation
8%
Atherogenesis
8%
4 Iodo 2,5 Dimethoxyamphetamine
8%
Thrombogenicity
8%
Acyltransferase
8%
Lysophosphatidylcholine
8%
Lysophosphatidic Acid Receptor
8%
Enzyme Regulation
8%
Hydrolase
8%
Biochemistry, Genetics and Molecular Biology
Homeostasis
100%
Lysophosphatidic Acid
100%
Lipid
30%
Phospholipase A
15%
Precursor
7%
Enzyme
7%
RNA
7%
N-Acetyltransferase
7%
Acyltransferase
7%
Liquid Chromatography-Mass Spectrometry
7%
LDL Receptor
7%
2,5-Dimethoxy-4-iodoamphetamine
7%
Hydrolase
7%
Enzyme Regulation
7%
Platelet
7%
Lysophosphatidylcholine
7%
Pharmacology, Toxicology and Pharmaceutical Science
Lysophosphatidic Acid
100%
Acid
16%
Phospholipase A
16%
2,5-Dimethoxy-4-iodoamphetamine
8%
Acyltransferase
8%
Disease Exacerbation
8%
Low Density Lipoprotein Receptor
8%
Atherogenesis
8%
Lysophosphatidylcholine
8%
Thrombogenicity
8%
Lysophosphatidic Acid Receptor
8%
Hydrolase
8%